The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
Abstract
OBJECTIVE: Recent studies suggest the beneficial effects of metformin on glucose metabolism may be microbially mediated. We examined the association of type 2 diabetes, metformin, and gut microbiota in community-dwelling Colombian adults. On the basis of previous research, we hypothesized that metformin is associated with higher levels of short-chain fatty acid (SCFA)–producing and mucin-degrading microbiota. RESEARCH DESIGN AND METHODS: Participants were selected from a larger cohort of 459 participants. The present analyses focus on the 28 participants diagnosed with diabetes—14 taking metformin— and the 84 participants without diabetes who were matched (3-to-1) to participants with diabetes by sex, age, and BMI. We measured demographic information, anthropometry, and blood biochemical parameters and collected fecal samples from which we performed 16S rRNA gene sequencing to analyze the composition and structure of the gut microbiota. RESULTS: We found an association between diabetes and gut microbiota that was modified by metformin use. Compared with participants without diabetes, participants with diabetes taking metformin had higher relative abundance of Akkermansia muciniphila, a microbiota known for mucin degradation, and several gut microbiota known for production of SCFAs, including Butyrivibrio, Bifidobacterium bifidum, Megasphaera, and an operational taxonomic unit of Prevotella. In contrast, compared with participants without diabetes, participants with diabetes not taking metformin had higher relative abundance of Clostridiaceae 02d06 and a distinct operational taxonomic unit of Prevotella and a lower abundance of Enterococcus casseliflavus. CONCLUSIONS: Our results support the hypothesis that metformin shifts gut microbiota composition through the enrichment of mucin-degrading A. muciniphila as well as several SCFA-producing microbiota. Future studies are needed to determine if these shifts mediate metformin’s glycemic and anti-inflammatory properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Biguanides/metformin, the first-line therapeutics for T2D, modifies microbiota leading to an increase in A. muciniphila, as well as several SCFA-producing microbiota, favoring an improvement on mucin-producing goblet cells, pro-inflammatory IL-6, and glucose tolerance [304].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [304]
In the citing paper
“In human diabetic individuals, metformin was shown to shift gut microbiota composition to predominantly short-chain fatty-acid producing microbes”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as de la Cuesta-Zuluaga et al. 2017
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192 · cited 2×
“pairwise tests among groups of participants using the unpaired Wilcoxon rank sum test, and finally uses LDA to estimate the effect size of each differentially abundant OTU (24).”
MethodKozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., & Schloss, P. D. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01043-13 · Cited by 7,112
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762 · cited 1×
“Given the considerable variation in the microbiota associated with type 2 diabetes and that the gut microbiota of Colombians is different to that of other populations (18), we hypothesized that the microbial taxa involved in the type 2 diabetes dysbiosis of Colombians are different to those observed in Chinese and Eur…”
BackgroundLinking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513 · cited 1×
“Prevotella has been associated with carbohydrate-baseddiets anddegradation of complex polysaccharides (26), whereas E.”
BackgroundCross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · cited 3×
“abundance of Akkermansia muciniphila (11–13), a mucin-degrading bacteria that has been shown to reverse metabolic disorders (1,12).”
BackgroundInfluentialGut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · cited 1×
“Given the considerable variation in the microbiota associated with type 2 diabetes and that the gut microbiota of Colombians is different to that of other populations (18), we hypothesized that the microbial taxa involved in the type 2 diabetes dysbiosis of Colombians are different to those observed in Chinese and Eur…”
BackgroundGut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851 · cited 1×
“through effects on bile acid secretion (31).”
Cited by
Items 201–300 of 731
Comorbidities, Associated Diseases, and Risk Assessment in COVID‐19—A Systematic Review
Fitero, A., BUNGAU, S. G., Ţiţ, D. M., Endres, L. M., Khan, S. A., Bungău, A. F., Romanul, I. M., Vesa, C. M., Radu, A.-F., Tarce, A. G., et al. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/1571826 · Cited by 57
“,e patients treated with Metformin before COVID-19 had a mortality rate of 11%, slightly like the one observed in the overall population, but those without metformin administration encountered a rate of 24% [60].”
Gut microbiota and therapy for obesity and type 2 diabetes
Zhang, L., Wang, P., Huang, J., Xing, Y., Wong, F. S., Suo, J., & Li, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1333778 · Cited by 73
Cheng, D., Song, J., Xie, M., & Song, D. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.07.044 · Cited by 58
Li, Y., Ji, X., Wu, H., Xiang, L., Zhang, H., & Tang, D. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114207 · Cited by 61
Tingler, A. M., & Engevik, M. A. (2025) · Infection and Immunity · doi:10.1128/iai.00503-24 · Cited by 64
Metagenomic analyses of the gut microbiota associated with colorectal adenoma
Saito, K., Koido, S., Odamaki, T., Kajihara, M., Kato, K., Horiuchi, S., Adachi, S., Arakawa, H., Yoshida, S., Akasu, T., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212406 · Cited by 57
Almugadam, B. S., Liu, Y., Chen, S.-M., Wang, C., Shao, C., Ren, B.-W., Tang, L., & Hatziagelaki, E. E. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7253978 · Cited by 55
The Emerging Biotherapeutic Agent: Akkermansia
Kalia, V. C., Gong, C., Shanmugam, R., Lin, H. M., Zhang, L., & Lee, J.-K. (2021) · Indian Journal of Microbiology · doi:10.1007/s12088-021-00993-9 · Cited by 56
McMurdie, P. J., Stoeva, M. K., Justice, N., Nemchek, M. P., Sieber, C. M. K., Tyagi, S., Gines, J., Skennerton, C. T., Souza, M., Kolterman, O., et al. (2022) · BMC Microbiology · doi:10.1186/s12866-021-02415-8 · Cited by 58
Sexual dimorphism in the response to chronic circadian misalignment on a high-fat diet
Anderson, S. T., Meng, H., Brooks, T. G., Tang, S. Y., Lordan, R., Sengupta, A., Nayak, S., Mřela, A., Sarantopoulou, D., Lahens, N. F., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo2022 · Cited by 57
Dietary Patterns Affect the Gut Microbiome—The Link to Risk of Cardiometabolic Diseases
Tindall, A. M., Petersen, K. H., & Kris‐Etherton, P. M. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy141 · Cited by 60
Liu, Y., Qin, S., Feng, Y., Song, Y., Lv, N., Liu, F., Zhang, X., Wang, S., Wei, Y., Li, S., et al. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174420000768 · Cited by 57
Dapagliflozin Modulates the Fecal Microbiota in a Type 2 Diabetic Rat Model
Yang, M., Shi, F., Liu, W., Zhang, M.-C., Feng, R., Cheng, Q., Liu, W., & Ma, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00635 · Cited by 56
“Metformin is a first-line medication in the treatment of type 2 diabetes, as it increases the abundance of beneficial bacteria (4, 5), and is associated with higher levels of short-chain fatty acids (SCFAs: acetate, propionate, and butyrate) (6).”
BackgroundBile acid metabolism and signaling: Emerging pharmacological targets of dietary polyphenols
Tveter, K. M., Mezhibovsky, E., Wu, Y., & Roopchand, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108457 · Cited by 53
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review
Sosnowski, K., & Przybyłkowski, A. M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2393272 · Cited by 58
Payahoo, L., Khajebishak, Y., Alivand, M. R., Soleimanzade, H., Alipour, S., Barzegari, A., & Ostadrahimi, A. (2019) · Appetite · doi:10.1016/j.appet.2019.05.032 · Cited by 57
García-Vega, Á. S., Corrales-Agudelo, V., Reyes, A., & Escobar, J. S. (2020) · Nutrients · doi:10.3390/nu12102938 · Cited by 55
“A detailed description of the laboratory and bioinformatic procedures used to generate, process and analyze the gut microbiota of participants can be found elsewhere [30].”
MethodSelf-citationDu, H., Shi, L. S., Wang, Q., Yan, T., Wang, Y., Zhang, X., Yang, C., Zhao, Y., & Yang, X. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c04888 · Cited by 52
Rutin alleviates colon lesions and regulates gut microbiota in diabetic mice
Cai, C., Cheng, W., Shi, T., Liao, Y., Zhou, M., & Liao, Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-31647-z · Cited by 51
Gut microbiota regulates cardiac ischemic tolerance and aortic stiffness in obesity
Battson, M. L., Lee, D. M., Puma, L. C. L., Ecton, K. E., Thomas, K. N., Febvre, H. P., Chicco, A. J., Weir, T. L., & Gentile, C. L. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00346.2019 · Cited by 55
Shin, N. R., Gu, N., Choi, H. S., & Kim, H. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00221.2019 · Cited by 54
Immune Memory in Aging: a Wide Perspective Covering Microbiota, Brain, Metabolism, and Epigenetics
Bulut, O. P., Kılıç, G., & Domínguez‐Andrés, J. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08905-x · Cited by 56
The gut microbiota-artery axis: A bridge between dietary lipids and atherosclerosis?
Zhang, Q., Zhang, L., Chen, C., Li, P., & Lu, B. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101209 · Cited by 53
Chen, Y., Shen, X., Ma, T., Yu, X., Kwok, L. Y., Li, Y., Sun, Z., Li, D., & Zhang, H. (2023) · mSystems · doi:10.1128/msystems.01300-22 · Cited by 55
“oral intake but not via intravenous injection, implying that the mechanism of action of metformin is directly related to the gastrointestinal tract (32, 33).”
BackgroundMechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes
Zhou, Y.-D., Liang, F.-X., Tian, H.-R., Luo, D., Wang, Y., & Yang, S. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1121695 · Cited by 58
Alterations in Gut Microbiota and Immunity by Dietary Fat
Yang, B., Hur, K. Y., & Lee, M. (2017) · Yonsei Medical Journal · doi:10.3349/ymj.2017.58.6.1083 · Cited by 53
“Intriguingly, metformin administration greatly increases the abundance of Akkermansia in patients with type 2 diabetes as well.(45,46) While these results suggest potential therapeutic value of Akkermansia or its components as a drug candidate against metabolic syndrome, such prospects have been hampered by the sensit…”
BackgroundHuang, X., Hong, X., Wang, J., Sun, T., Yu, T., Yu, Y., Fang, J., & Xiong, H. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103037 · Cited by 51
“Raw sequences from 3 articles [13,32,33] were processed and differential analyses between metformin-treated and metformin-untreated humans or rodents were performed.”
InfluentialFu, Y., Yin, R., Liu, Z., Niu, Y., Guo, E., Cheng, R., Diao, X., Xue, Y., & Shen, Q. (2020) · Nutrients · doi:10.3390/nu12113452 · Cited by 51
Sanjiwani, M. I. D., Aryadi, I. P. H., & Semadi, I. M. S. (2022) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.037.01.13 · Cited by 54
Cao, T. T. B., Wu, K., Hsu, J., Chang, C., Chou, C., Lin, C.-Y., Liao, Y.-M., Lin, P.-C., Yang, L., & Lin, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.573891 · Cited by 54
“Phylum Actinobacteria P_Actinobacteria 5 ↔ ↑ ↔, ↓ ↓ F_Bifidobacteriaceae 2 ↓ ↑ G_Bifidobacterium 8 ↔(2), ↑, ↓ ↑ ↑ ↑ ↓ S_Bifidobacterium spp. 2 ↓ ↔ G_Corynebacterium 1 2 ↔ ↑ G_Enterorhabdus 2 ↔ ↓ Phylum Cyanobacteria P_Cyanobacteria 2 ↓ ↓ ↑ ↓ Phylum Elusimicrobia P_Elusimicrobia 2 ↔ ↓ G_Allobaculum 10 ↔, ↓ (2), ↑ (2) ↑…”
BackgroundInfluentialDeng, Z., Wu, N., Wang, J., Geng, L., Yue, Y., Wang, F., & Zhang, Q. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.10.188 · Cited by 51
Cheng, X., Zhang, Y., Li, Y., Wu, Q., Wu, J., Park, S., Guo, C., & Lu, J. (2022) · BMC Microbiology · doi:10.1186/s12866-022-02686-9 · Cited by 49
Metformin Mitigates Sepsis-Related Neuroinflammation via Modulating Gut Microbiota and Metabolites
Zhao, H., Lyu, Y., Zhai, R., Sun, G., & Ding, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.797312 · Cited by 52
Adeshirlarijaney, A., Zou, J., Tran, H. Q., Chassaing, B., & Gewirtz, A. T. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00245.2019 · Cited by 47
Wang, F., Wan, Y., Yin, K., Wei, Y., Wang, B., Yu, X., Ni, Y., Zheng, J., Huang, T., Song, M., et al. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900612 · Cited by 52
Liu, Y., & Lou, X. (2020) · Clinics · doi:10.6061/clinics/2020/e1277 · Cited by 51
“metformin had increased mucosal eosinophils and bacteria producing SCFAs (99).”
BackgroundInfluentialTherapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota
Zhao, X., Oduro, P. K., Tong, W., Wang, Y., Gao, X., & Wang, Q. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105362 · Cited by 49
Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites
Wang, D., Liu, J. Y., Zhou, L., Zhang, Q., Li, M., & Xiao, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.905171 · Cited by 52
Rosell-Díaz, M., Petit-Gay, A., Molas-Prat, C., Gallardo‐Nuell, L., Ramió‐Torrentà, L., Garre‐Olmo, J., Pérez‐Brocal, V., Moyá, A., Jové, M., Pamplona, R., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155941 · Cited by 53
Probiotic strains and mechanistic insights for the treatment of type 2 diabetes
Hampe, C. S., & Roth, C. L. (2017) · Endocrine · doi:10.1007/s12020-017-1433-z · Cited by 48
Li, L., Zhang, X., Ning, Z., Mayne, J., Moore, J. I., Butcher, J., Chiang, C., Mack, D. R., Stintzi, A., & Figeys, D. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00461 · Cited by 54
Akkermansia muciniphila May Determine Chondroitin Sulfate Ameliorating or Aggravating Osteoarthritis
Wang, Q., Huang, S.-Q., Li, C., Xu, Q., & Zeng, Q.-P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01955 · Cited by 48
“Enrichment of gut A. muciniphila populations has been observed in diabetes patients treated with metformin (de la Cuesta-Zuluaga et al., 2017), and following weight loss in obese and/or type 2 diabetes patients (Remely et al., 2016).”
BackgroundImpact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?
Debédat, J., Amouyal, C., Aron‐Wisnewsky, J., & Clément, K. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00738-3 · Cited by 48
“A recent meta-analysis [132] summarized the changes in GM composition post-BS and showed that among the plethora of bacterial changes, two genera, Escherichia and Akkermansia, have been consistently reported to s t rongly increased post -BS [132] .”
BackgroundZhang, Y., Zhao, N., Yang, L., Hong, Z., Cai, B., Le, Q., Yang, T., Shi, L., He, J., & Cui, C. (2020) · Food & Function · doi:10.1039/d0fo02380a · Cited by 47
Pleiotropic Effects of Metformin on the Antitumor Efficiency of Immune Checkpoint Inhibitors
Liu, W., Wang, Y., Luo, J., Liu, M., & Luo, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586760 · Cited by 50
“muciniphila in individuals who received metformin for four months (50).”
BackgroundYin, Y., Sripetchwandee, J., Chattipakorn, N., & Chattipakorn, S. C. (2021) · Anaerobe · doi:10.1016/j.anaerobe.2021.102361 · Cited by 45
Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders
Kobyliak, N. M., Falalyeyeva, T. M., Kyriachenko, Y., TSEYSLYER, Y., KOVALCHUK, O., HADILIIA, O., Eslami, M., YOUSEFI, B., Abenavoli, L., Fagoonee, S., et al. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.22.03752-6 · Cited by 50
Wei, M., Hu, Z., Xu, L., Bian, X., Lian, W., Yin, S., Zhao, S., Gao, W., Guo, C., & Shi, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.983358 · Cited by 47
Health and Disease:Akkermansia muciniphila, the Shining Star of the Gut Flora
Xue, C., Li, G., Gu, X., Su, Y., Zheng, Q., Yuan, X. H., Bao, Z., Lu, J., & Li, L. (2023) · Research · doi:10.34133/research.0107 · Cited by 52
The Gut Microbiota-Related Antihyperglycemic Effect of Metformin
Szymczak-Pajor, I., Drzewoski, J., Kozłowska, M., Krekora, J., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18010055 · Cited by 44
“…found to be increased in patients treated with metformin [56,200,201], as has an increase in the number of bacteria responsible for the production of SCAFs, especially Blautia , Akkermansia , Bifidobacterium , Shewanella , Lactobacillus , Butyrivibrio , Megasphaera , and Prevotella [56,57,200].”
Orlistat‐Induced Gut Microbiota Modification in Obese Mice
Ke, J., An, Y., Cao, B., Lang, J., Wu, N., & Zhao, D. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/9818349 · Cited by 50
Role of Gut Microbial Metabolites in Cardiovascular Diseases—Current Insights and the Road Ahead
Datta, S., Pasham, S., Sandeep, I. S., Boini, K. M., & Koka, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810208 · Cited by 46
Pedersen, C., Ijaz, U. Z., Gallagher, E., Horton, F., Ellis, R. J., Jaiyeola, E., Duparc, T., Russell-Jones, D. L., Hinton, P. J., Cani, P. D., et al. (2018) · Physiological Reports · doi:10.14814/phy2.13649 · Cited by 47
Xu, J., Li, T., Xia, X., Fu, C., Wang, X., & Zhao, Y. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c04429 · Cited by 42
Shoshan‐Barmatz, V., Anand, U., Crystal, E. N., Carlo, M. D., & Shteinfer‐Kuzmine, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730048 · Cited by 44
Type 2 Diabetes and the Microbiome
Barlow, G. M., & Mathur, R. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac184 · Cited by 49
Bataineh, M. T. A., Künstner, A., Dash, N. R., AlSafar, H. S., Ragab, M., Schmelter, F., Sina, C., Busch, H. S., & Ibrahim, S. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-45066-7 · Cited by 44
Baroni, I., Fabrizi, D., Luciani, M., Magon, A., Conte, G., Angeli, G. D., Paglione, G., Ausili, D., & Caruso, R. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.03.006 · Cited by 44
Wang, Y., Jia, X., & Cong, B. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1396031 · Cited by 49
Microbiome modulation to correct uremic toxins and to preserve kidney functions
Caggiano, G., Cosola, C., Leo, V. D., Gesualdo, M., & Gesualdo, L. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000565 · Cited by 42
Tveter, K. M., Villa-Rodríguez, J. A., Cabales, A., Zhang, L., Bawagan, F. G., Duran, R. M., & Roopchand, D. E. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001386 · Cited by 42
Nakajima, H., Takewaki, F., Hashimoto, Y., Kajiyama, S., Majima, S., Okada, H., Senmaru, T., Ushigome, E., Nakanishi, N., Hamaguchi, M., et al. (2020) · Life · doi:10.3390/life10090195 · Cited by 49
“However, existing studies on the effects of metformin on gut microbiota have been carried out in Western countries and China [11,13], and as such, we know that the gut microbiota’s characteristics vary between countries, including in patients with T2DM [14,15].”
BackgroundMetformin: Metabolic Rewiring Faces Tumor Heterogeneity
Cioce, M., Pulito, C., Strano, S., Blandino, G., & Fazio, V. M. (2020) · Cells · doi:10.3390/cells9112439 · Cited by 42
“For instance, an effect of metformin on the abundance of intestinal Akkermansia muciniphila has been reproducibly reported [61,64].”
BackgroundGhorbani, Y., Schwenger, K. J. P., & Allard, J. P. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02520-4 · Cited by 42
Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease
Chen, R., Zhu, D., Yang, R., Wu, Z., Xu, N., Chen, F., Zhang, S., Chen, H., Li, M., & Hou, K. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-2926 · Cited by 47
“Firmicutes were decreased and SCFA-producing bacteria abundance increased in T2DM patients treated with metformin compared with placebo (44).”
Biofilm battle: New transformative tactics to tackle the bacterial biofilm infections
Upadhyay, A., Jaiswal, N., & Kumar, A. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107277 · Cited by 42
The gut microbiome in differential diagnosis of diabetic kidney disease and membranous nephropathy
Yu, W., Shang, J., Guo, R., Zhang, F., Zhang, W., Zhang, Y., Wu, F., Ren, H., Liu, C., Xiao, J., et al. (2020) · Renal Failure · doi:10.1080/0886022x.2020.1837869 · Cited by 41
Chu, S., Zhang, F., Wang, H., Xie, L., Chen, Z., Zeng, W., Zhou, Z., & Hu, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.907702 · Cited by 43
“Both first-line drug metformin and traditional Chinese medicine can significantly alter the composition of the gut microbiota, thus helping to ameliorate hyperglycemia (Xu et al., 2015; de la Cuesta-Zuluaga et al., 2017; Wang et al., 2017; Bauer et al., 2018).”
BackgroundRoessler, J., Leistner, D. M., Landmesser, U., & Haghikia, A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.08.018 · Cited by 40
Metformin and the Liver: Unlocking the Full Therapeutic Potential
Perazza, F., Leoni, L., Colosimo, S., Musio, A., Bocedi, G., D’Avino, M., Agnelli, G., Nicastri, A., Rossetti, C., Sacilotto, F., et al. (2024) · Metabolites · doi:10.3390/metabo14040186 · Cited by 43
“…fa tt y acids with positive actions on peripheral tissues (adipose tissue, skeletal muscle, and liver) by improving insulin sensitivity [49,51,52], and reduced reabsorption of bile acids in the distal ileum, resulting in increasing bile salt levels within the colon, which might modify its…”
BackgroundWang, J., Bose, S., Lim, S.-K., Ansari, A., Chin, Y., Choi, H. S., & Kim, H. (2017) · Genes · doi:10.3390/genes8100239 · Cited by 38
“In an earlier study, based on the experimental evidence, it has been hypothesized that metformin shifts gut microbiota composition through the enrichment of Akkermansia muciniphila [52], the mucin-degrading bacterium which has also been shown to be inversely correlated with the onset of inflammation, altered adipose t…”
BackgroundJi, S., Wang, L., & Li, L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00704 · Cited by 39
Balvers, M., Deschasaux, M., van den Born, B. H., Zwinderman, A. H., Nieuwdorp, M., & Levin, E. (2021) · Nutrients · doi:10.3390/nu13093289 · Cited by 44
“For instance, a lower abundance of butyrate producers has been reported in diabetes [9,10], which is consistent with our results of several ASVs assigned to potential butyrate producing genera that showed a lower abundance in Met-T2D cases in both ethnicities [18,65].”
BackgroundResultHabitual animal fat consumption in shaping gut microbiota and microbial metabolites
Wan, Y., Tong, W., Zhou, R., Li, J., Yuan, J., Wang, F., & Li, D. (2019) · Food & Function · doi:10.1039/c9fo01490j · Cited by 40
Huang, J., Huang, J., Li, Y., Lv, H., Yin, T., Fan, S., Zhang, C., & Li, H. (2021) · Journal of Medicinal Food · doi:10.1089/jmf.2021.k.0030 · Cited by 41
“42 One of the sequenced bands from the Fuc2.”
Fang, X., Li, F., & Hong, D. (2021) · Current Medical Science · doi:10.1007/s11596-021-2464-5 · Cited by 41
Kant, R., Chandra, L., Verma, V. K., Nain, P., Bello, D., Patel, S., Ala, S., Chandra, R., & Antony, M. A. (2022) · World Journal of Methodology · doi:10.5662/wjm.v12.i4.246 · Cited by 39
Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review)
Liu, Q., Liu, S., Chen, L., Zhao, Z., Du, S.-X., Dong, Q., Xin, Y., & Xuan, S. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7781 · Cited by 51
Hassan, A. K., El-kotby, D. A., Tawfik, M. M., Badr, R. E., & Bahgat, I. M. (2019) · The Journal of Basic and Applied Zoology · doi:10.1186/s41936-019-0127-x · Cited by 38
“American Diabetes Association (2017).”
BackgroundCharting the Maternal and Infant Microbiome: What Is the Role of Diabetes and Obesity in Pregnancy?
Singh, S., Karagas, M. R., & Mueller, N. T. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0836-9 · Cited by 42
Self-citationProbing the Interface of HIV and Inflammaging
Sieg, S. F., Shive, C. L., Panigrahi, S., & Freeman, M. L. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00547-0 · Cited by 39
Xiong, J., Chen, X., Zhao, Z., Liao, Y., Zhou, T., & Xiang, Q. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11536 · Cited by 38
The pathogenic role of intestinal flora metabolites in diabetic nephropathy
Tian, E., Wang, F., Zhao, L., Sun, Y., & Yang, J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1231621 · Cited by 36
Early intestinal microbiota changes in aged and adult mice with sepsis
Yuan, Y., Liu, S., Ding, X., Li, Y., Zhang, X., Song, H., Qi, X., Zhang, Z., Guo, K., & Sun, T. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1061444 · Cited by 38
“Prevote l la and Muribaculaceae have positive effects on the intestine via immune regulation and intestinal homeostasis regulation (Zhang et al., 2015; de la Cuesta-Zuluaga et al., 2017).”
BackgroundDixon, S. A., Mishra, S. P., DIETSCHE, K. B., Jain, S., Mabundo, L. S., Stagliano, M. S., Krenek, A. M., Courville, A. B., Yang, S. B., Turner, S. A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1125187 · Cited by 38
Lv, Y., Zhao, X. Y., Guo, W., Gao, Y., Yang, S., Li, Z., & Wang, G. (2018) · Journal of Diabetes Research · doi:10.1155/2018/1890978 · Cited by 37
“The higher abundance ofAkkermansia muciniphila was involved in maintaining mucin layer integrity [45, 46], and the changes in gut microbiota were attributed to SCFA-producing bacteria in human and animal guts [45, 46].”
BackgroundIsop, L. M., Neculau, A. E., Necula, R. D., Kakucs, C., Moga, M., & Dima, L. (2023) · Pharmaceuticals · doi:10.3390/ph16121714 · Cited by 41
“…receiving metformin showed greater abundance of mucin-degrading bacteria and GM bacteria that produce short-chain fa tt y acids (SCFAs) [104,105]. cantly by ethnicity, the enrichment of Bacteroides operational taxonomic units and the reduction in Faecalibacterium units are the therapy’s de…”
Metformin: update on mechanisms of action on liver diseases
Ruan, G., Wu, F., Shi, D., Sun, H., Wang, F., & Xu, C. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1327814 · Cited by 34
Feng, J., Yang, J. T., Chang, Y.-J., Qiao, L., Dang, H., Luo, K., Guo, H., An, Y.-N., Ma, C., Shao, H., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0396-4 · Cited by 36
Pîrcălăbioru, G. G., Liaw, J., Gundogdu, O., Corcionivoschi, N., Ilie, I., Oprea, L., Muşat, M., & Chifiriuc, M. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147509 · Cited by 40
Biofilms associated with poultry processing equipment.
Lindsay, D., Geornaras, I., & von Holy, A. (1996) · PubMed · Cited by 43
Fliegerova, K. O., Mahayri, T. M., Sechovcová, H., Mekadim, C., Mrázek, J., Jarošíková, R., Dubský, M., & Fejfarová, V. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1451054 · Cited by 41
Drug-microbiota interactions and treatment response: Relevance to rheumatoid arthritis
Sayers, E., MacGregor, A. J., & Carding, S. R. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.4.642 · Cited by 36
Cuyàs, E., Fernández‐Arroyo, S., Buxó, M., Pernas, S., Dorca, J., Álvarez, I., Torres‐Martínez, S., Pérez-García, J. M., Batista-López, N., Rodríguez‐Sánchez, C. A., et al. (2019) · Aging · doi:10.18632/aging.101960 · Cited by 34
Gastrointestinal surgery and the gut microbiome: a systematic literature review
Ferrie, S., Webster, A., Wu, B., Tan, C. Q. Y., & Carey, S. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0681-9 · Cited by 33
Han, Y., Kwon, E., & Choi, M. (2020) · Nutrients · doi:10.3390/nu12072113 · Cited by 34
Kangwan, N., Pratchayasakul, W., Kongkaew, A., Pintha, K., Chattipakorn, N., & Chattipakorn, S. C. (2021) · Nutrients · doi:10.3390/nu13093141 · Cited by 35
Petakh, P., Kamyshna, I. I., Oksenych, V., Kainov, D. E., & Kamyshnyi, O. (2023) · Pharmaceuticals · doi:10.3390/ph16060904 · Cited by 36
Metformin, Microbiome and Protection Against Colorectal Cancer
Jones, G. R. D., & Molloy, M. P. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06390-4 · Cited by 36
“While broad direct and indirect biochemical mechanisms have been reported for metformin’s anti-cancer activity [11], there is growing support that metabolic interactions elicited with the gut microbiome may be significant contributors to metformin’s protection against CRC [23, 24] (Fig.”
BackgroundQin, X., Chen, M., He, B., Chen, Y., & Zheng, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1539972 · Cited by 34
Metadata
- Authors
- de la Cuesta-Zuluaga, J., Mueller, N. T., Corrales-Agudelo, V., Velásquez-Mejía, E. P., Carmona, J. A., Abad, J. M., & Escobar, J. S.
- Affiliations
- Vidarium—Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Medellin, Colombia
- Johns Hopkins University (US)
- Vidarium - Centro de Investigación en Nutrición Salud y Bienestar (CO)
- Dinámica I.P.S.—Especialista en Ayudas Diagnósticas, Medellin, Colombia
- EPS y Medicina Prepagada Suramericana S.A., Medellin, Colombia
- Corresponding author
- Escobar, Juan S.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-11-14
- Volume
- 40
- Issue
- 1
- Pages
- 54-62
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2553515186
- Cited by
- 704
- References
- 40
- Citations by year
- 2026: 55 · 2025: 69 · 2024: 86 · 2023: 80 · 2022: 106 · 2021: 78 · 2020: 87 · 2019: 62 · 2018: 45 · 2017: 33 · 2016: 1
- FWCI
- 24.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- metformin, Akkermansia muciniphila, gut microbiota, short-chain fatty acids, type 2 diabetes, mucin degradation, Butyrivibrio, Bifidobacterium bifidum, Megasphaera, Prevotella, Clostridiaceae, Enterococcus casseliflavus, fecal microbiota composition, glycemic control
- MeSH terms
- Gastrointestinal Microbiome, Adolescent, Adult, Colombia, Diabetes Mellitus, Type 2, Fatty Acids, Volatile, Feces, Female, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Mucins, RNA, Ribosomal, 16S, Case-Control Studies, Verrucomicrobia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.